Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.040
-0.060 (-1.94%)
At close: Jan 30, 2026, 4:00 PM EST
3.115
+0.075 (2.47%)
After-hours: Jan 30, 2026, 6:12 PM EST
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of $101.47 million as of January 30, 2026. Its market cap has increased by 38.24% in one year.
Market Cap
101.47M
Enterprise Value
86.50M
1-Year Change
38.24%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $101.47M, an increase of 21.95%. That is a compound annual growth rate of 0.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 101.50M | -1.17% |
| Dec 31, 2025 | 102.70M | 37.48% |
| Dec 31, 2024 | 74.70M | -38.06% |
| Dec 29, 2023 | 120.60M | -7.44% |
| Dec 30, 2022 | 130.30M | 46.40% |
| Dec 31, 2021 | 89.00M | 21.92% |
| Dec 31, 2020 | 73.00M | 10.11% |
| Dec 31, 2019 | 66.30M | -10.04% |
| Dec 31, 2018 | 73.70M | 106.44% |
| Dec 29, 2017 | 35.70M | -24.52% |
| Dec 30, 2016 | 47.30M | 79.85% |
| Dec 31, 2015 | 26.30M | 10.04% |
| Dec 31, 2014 | 23.90M | -39.34% |
| Dec 31, 2013 | 39.40M | 18.32% |
| Dec 31, 2012 | 33.30M | 73.44% |
| Dec 30, 2011 | 19.20M | -39.81% |
| Dec 31, 2010 | 31.90M | -65.14% |
| Dec 31, 2009 | 91.50M | 61.95% |
| Dec 31, 2008 | 56.50M | -63.00% |
| Dec 31, 2007 | 152.70M | 62.27% |
| Dec 29, 2006 | 94.10M | 31.24% |
| Dec 30, 2005 | 71.70M | -0.42% |
| Dec 31, 2004 | 72.00M | 94.07% |
| Dec 31, 2003 | 37.10M | 183.21% |
| Dec 31, 2002 | 13.10M | -52.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cibus | 105.73M |
| Oncolytics Biotech | 105.53M |
| Alpha Cognition | 105.23M |
| Champions Oncology | 103.88M |
| Seer, Inc. | 102.38M |
| Coya Therapeutics | 97.30M |
| Agenus | 96.58M |
| Cognition Therapeutics | 96.22M |